Drug intelligence / Profile preview

normal saline + epinephrine

Development stage
Unknown
Lead developer
ARS Pharmaceuticals
Modality
Small Molecules
Administration
Perineural
01

Overview

This intervention is a placebo control formulation used in clinical research conducted by the University of California, San Diego, specifically for managing postoperative pain following hip arthroscopy. It consists of a combination of normal saline (0.9% sodium chloride) and epinephrine, administered via a Pericapsular Nerve Group (PENG) block. The PENG block is an ultrasound-guided regional anesthetic technique that targets the sensory articular branches of the femoral, obturator, and accessory obturator nerves located in the fascial plane between the psoas muscle and the pubic ramus. While the saline serves as an inactive volume replacement, the epinephrine acts as a vasoconstrictor to mimic the clinical conditions of the active treatment arm (bupivacaine) and to assist in maintaining the triple-masking of the trial by potentially inducing minor localized physiological effects.

Other names
normal saline + PENG block-University of California, San Diego-postoperative pain0.9% Sodium Chloride + epinephrineSaline PENG block
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)ADRB2 (β2)ADRA2 (Adrenergic alpha-2 receptor family)ADRB1 (β1)

Beyond the preview

Go deeper on normal saline + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on normal saline + epinephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call